Out, damned dot: studies of the NADPH oxidase in atherosclerosis
- PMID: 11714732
- PMCID: PMC209430
- DOI: 10.1172/JCI14453
Out, damned dot: studies of the NADPH oxidase in atherosclerosis
Comment on
-
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice.J Clin Invest. 2001 Nov;108(10):1513-22. doi: 10.1172/JCI11927. J Clin Invest. 2001. PMID: 11714743 Free PMC article.
References
-
- Guzik TJ, et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86:E85–E90. - PubMed
-
- Kirk EA, et al. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2000;20:1529–1535. - PubMed
-
- Souza HP, Laurindo FRM, Ziegelstein RC, Berlowitz CO, Zweier JL. Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am J Physiol Heart Circ Physiol. 2001;280:H658–H667. - PubMed
-
- Hsich E, et al. Vascular effects following homozygous disruption of p47(phox): an essential component of NADPH oxidase. Circulation. 2000;101:1234–1236. - PubMed
